Share on StockTwits

Varian Medical Systems (NYSE:VAR) SVP John W. Kuo sold 1,745 shares of the stock on the open market in a transaction dated Monday, June 23rd. The shares were sold at an average price of $85.00, for a total transaction of $148,325.00. Following the sale, the senior vice president now directly owns 14,061 shares in the company, valued at approximately $1,195,185. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Varian Medical Systems (NYSE:VAR) traded down 1.54% on Tuesday, hitting $83.27. 543,703 shares of the company’s stock traded hands. Varian Medical Systems has a 52 week low of $65.70 and a 52 week high of $86.60. The stock’s 50-day moving average is $82.04 and its 200-day moving average is $81.38. The company has a market cap of $8.656 billion and a price-to-earnings ratio of 21.71.

Varian Medical Systems (NYSE:VAR) last released its earnings data on Wednesday, April 23rd. The company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.01. The company had revenue of $779.00 million for the quarter, compared to the consensus estimate of $772.84 million. During the same quarter in the previous year, the company posted $1.04 earnings per share. The company’s revenue for the quarter was up 1.4% on a year-over-year basis. On average, analysts predict that Varian Medical Systems will post $4.30 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Morgan Stanley reiterated an “underweight” rating on shares of Varian Medical Systems in a research note on Wednesday, May 7th. They now have a $76.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems in a research note on Friday, April 25th. They now have a $83.00 price target on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $84.14.

Varian Medical Systems, Inc, is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.